The short position as a % of outsanding shares is about 4x what I see in CELG and BIIB.
I can only presume that some significant number or people
1) Expect Sovaldi to medically fail or
2) Expect government intervention on Sovaldi prices or
3) Expect competition to come sooner rather than later
I don't expect any of the above, but I think that's what is happening.
I was referring to market cap.
JNJ's market cap is about 280 billion but it does 71 billion in sales. No way GILD gets a market cap above JNJ's
No company is a 500 $BILLION company -- NOT A SINGLE ONE.
and no drug company with far less than $100 billion in sales will be the first
You're living in fantasy land if you expects a revenue beat of more than a $Billion.
But dopey -- just yesterday it would close at 85 -- yesterday.
You have zero credibility.
Dopey, the insiders have been BIG SELLERS for over a decade -- while the stock rose almost 1200%
"Why would Q2 be as good as Q1?"
Maybe because Sovaldi is being prescribed in a lot more countries than in Q1.
I agree. GILD may have another double in it over the next 2-3 years.
For it to go higher than that it will need at least one more real blockbuster big revenue drug in it''s quiver.
You must be up a whole 70 cents a share!!
While those of us that bought at 65-75 ...
well, you get the idea.
Oh, and that JAZZ you bought -- classic!!
No we won't. They can't announce a split because there are an insufficient number of treasury share to have a 2x1. Shareholders would need to vote to increase the number of treasury shares before any split could happen.
They can't announce a split because there are an insufficient number of treasury share to have a 2x1. Shareholders would need to vote to increase the number of treasury shares before any split could happen.
So would Quinn rather pay 200k to 500k patient to treat HepC over the patient's liefetime (recognizing that the patient would still have the disease), or 84k to cure it?
Well, the "overbought" pullback happened a week later than I thought it would, but it's here now.
With a few exceptions over the last two years, the 50 day has been a predictable support level for the stock. The 50 is somewhere around $82.50 right now.
"It's ok to be a skittish trader but you're never going to make big gains"
Perhaps you should be lecturing someone else about being a skittish trader.
1) I bought GILD in 2003 at a split adjusted $7/share
2 I bought US AIR at $3/share a few years back. It got converted to AAL stock at the buy out. It's worth $44/share now
3) I bought MU at $9/share early last year and it's worth $34/share now
4) I bought WDC at $45/share early last year. It crossed 100 bucks a share today for the first time in it's history.
There are others, but you get the picture.
The difference is that with a $130 billion market cap, GILD is done doubling every year.
It still will be a good one - over the next year. But it's going g down before it does go back up. See my other post in this thread.
However it's ability to keep doubling every few years is probably done. It's market cap is too large to keep up the pace of the past decade..
The likelihood that the stock price will increase in the next few months by 1/3 from today's level is pretty small.
I like casino gambling odds better.
It's overbought -- as measured by RSI.
EVER TIME in the last two years it has been overbought by that measure it has fallen - EVERY TIME.
I told everyone that two weeks ago.
This time is no different than the others.
lowest I've heard was about $11/pill in Egypt.
So why don't you tell us where it's going to be sold for $8/pill.